Genetic alteration of human CD34+ hematopoietic cells and transplantation into immunodeficient mice provides a humanized mouse model to study the leukemic potential of mutations and chromosomal aberrations found in AML without the potential confounding effects of the co-occurring mutations inherent to human AML cell lines and primary patient samples. This evidence concerns the gene CD34 and acute myeloid leukemia.